{
  "documents": [
    "Healthcare Professional Perspective JournalofPatientExperience Volume11: 1-5 Improving the Detection and Management TheAuthor(s)2024 Articlereuseguidelines: of Kidney Health in Primary Care sagepub. com/journals-permissions DOI: 10. 1177/23743735241256464 journals. sagepub. com/home/jpx Breonny Robson, BMedSc1, Gary Deed, MBBS, FACNEM2, 3, and Richard KS Phoon, MBBS, FRACP, GAICD4, 5 Abstract Chronickidneydisease(chronic kidney disease)isamajorcauseofmorbidityandmortality, contributingtoapproximately20000deathsin 2021 in Australia. Importantly, progression of chronic kidney disease can be substantially reduced if it is detected and treated early. Here we present the perspectives of a general practitioner (primary care physician), a nephrologist and a patient advocate on howthediagnosisandmanagementofCKDinprimarycarecouldbeimproved. EarlydetectionandtreatmentofCKDare impededby limitedpatient awarenessand knowledge, communication challenges between patients anddoctors, and psychosocialissues, withthesefactorsalsointeractingwith, andexacerbating, eachother. WemakethefollowingrecommendationstohelpimproveoutcomesinpatientswithCKD: (1)identifyingpeopleatincreasedriskofCKDandensuringthey have a complete Kidney health check (including estimated glomerular estimated glomerular filtration rate, Urine albumin-Creatinine ratio and a Blood Hypertension check) every 12 years; (2) using simple, nonconfrontational language and supportive resources to communicatewith patients about Kidney health; (3) implementing early treatment to slow the progression of chronic kidney disease and avoid adverse cardiovascular disease outcomes; and (4) asking patient-orientated questions to support shared decision-making and empower patients to be active partners in their healthcare. We acknowledge that limited time is a major barrier to implementing these recommendations in primary care. Utilizing the expertise of the whole practice team, and adopting supportive technology to introduce efficiencies, are likely to be of benefit. By adopting these recommendations, we believe general practitioners have the opportunity to drive improved outcomes and quality of life for people living with chronic kidney disease in Australia. Keywords chronic Kidney disease, albuminuria, awareness, patient-orientated, First Nations Australians Introduction to the Issue and a patient advocate on areas in which the management of kidneyhealthinAustralianprimarycarecouldbeimproved. Chronickidneydisease (chronic kidney disease) isa majorcause ofmorbidity and mortality in Australia, contributing to approximately Key Factors for Consideration 20000deathsin2021. 1Threein4Australiansareatincreased risk of chronic kidney disease and the disease is twice as common in First AwarenessofCKDandthefactorsthatincreaseCKDriskare NationsAustralians. 1, 2CKDprogressioncanbesubstantially inconsistent. GPs generally have a Good awareness that reduced if it is detected and treated early. 2, 3 It is estimated hypertension, Diabetes, family history, obesity and smoking that targeted early detection of chronic kidney disease over the next 20 years could generate 164956 years of healthy life, by preventing 1KidneyHealthAustralia, Melbourne, Victoria, Australia 38200prematuredeathsand237324hospitalizationsassoci2HealthcarePlusMedicalCentre, Coorparoo, Queensland, Australia ated with cardiovascular disease (cardiovascular disease). 4 In Australia, key 3MonashUniversity, Melbourne, Victoria, Australia areasthatmay impede earlydetectionandtreatmentofCKD 4DepartmentofRenalMedicine, CentreforTransplantandRenalResearch, WestmeadHospital, Westmead, Australia include a lack of awareness and knowledge, challenges with 5FacultyofMedicineandHealth, TheUniversityofSydney, Sydney, communication or interactions between patients and primary Australia healthcare providers due to poor health literacy and cultural/ CorrespondingAuthor: linguistic barriers, a lack of dedicated funding for targeted BreonnyRobson, KidneyHealthAustralia, Level2/18DequettevilleTce, screening, and psychosocial issues. 5 This article synthesizes KentTown, Adelaide5067, SouthAustralia. the viewpoints of a general practitioner (GP), a nephrologist, Email: Breonny. RobsonKidney. org. au CreativeCommonsCCBY: ThisarticleisdistributedunderthetermsoftheCreativeCommonsAttribution4. 0License( licenses/by/4. 0/)whichpermitsanyuse, reproductionanddistributionoftheworkwithoutfurtherpermissionprovidedtheoriginalworkisattributedas specifiedontheSAGEandOpenAccesspage( 2 Journal of Patient Experience increaseCKDrisk. 6However, upto90%ofkidneyfunction ItisoftenchallengingforGPstodiscusskidneyhealthor is lost before people experience symptoms, and patients a chronic kidney disease diagnosis with their patients without alarming them awarenessoftheirkidneyhealthandthefactorsthatincrease (and potentially losing them from care). To find the right chronic kidney disease risk is relatively Low. 2 According to an Australian balance, the use of simple, nonconfrontational language, Health Survey, only 6. 1% of patients with biomedical signs together with a collaborative, solution-focused approach ofCKDself-reportedtheircondition. 7Inasurveyofpatients between healthcare team and patient, may prove a useful with chronic kidney disease (stages 1-5), at least 70% of patients identified tactic.",
    "For example, discussing a patients Kidney hypertension, Diabetes, and obesity as chronic kidney disease risk factors; problem is less alarming than describing a patients weak however, only 54% and 38% recognized that chronic kidney disease was or failing kidneys, 9 and Kidney health may be more more common in people who smoked or were First Nation useful when discussing risk factors and lifestyle, rather Australian, respectively. 6 Furthermore, the patients awarethan Kidney disease. GPs may also consider referring to ness of comorbidities associated with chronic kidney disease was lower than the percentage of Kidney function (eg kidneys are working for other chronic conditions, and chronic kidney disease was perceived to at 50%) rather than the stage of chronic kidney disease, as the latter may pose less of a threat to life than Diabetes or cardiovascular disease. 6 Missed alarm patients due to perceived similarity with stages of opportunities for targeted detection of chronic kidney disease in High-risk cancer. 10 groups is common, particularly in First Nations For all people with a diagnosis of chronic kidney disease, management Australians, and can contribute to the late diagnosis and strategies aim to slow the decline of estimated glomerular filtration rate, reduce albupoor outcomes often seen in chronic kidney disease. 8 minuria, maintain Blood Hypertension below 130/80, lower When it comes to treatment for chronic kidney disease, people living with cardiovascular disease risk and avoid further damage to the kidneys. 2 the condition are often not aware that medications they Lifestyle modifications (stopping smoking, following a have been prescribed to treat hypertension, cholesterol, or balanced nutritional plan, limiting alcohol intake and Diabetes also have Kidney benefits. 5, 6 Furthermore, some increasingphysicalactivity)shouldbeconsideredthefirstpatients may be concerned about the cost of medications line strategy, with the addition of medications to slow and adverse effects, especially if they are taking multiple disease progression, reduce albuminuria, and manage medications. 5 This lack of understanding and awareness of Blood Hypertension if indicated (Figure 1). Following a chronic kidney disease chronic kidney disease and its treatment can lead to feelings of disbelief diagnosis, correctly coding chronic kidney disease in practice software will regarding diagnosis, anxiety about disease progression, and assist with medication considerations and can help uncertaintyaboutprognosis. 5Thesefeelingsmaybeintensiimprove the overall management of chronic kidney disease leading to posifiedifthereispoorcommunicationorinteractionbetweenthe tive outcomes for patients. Effective management can GP and patient. help patients to feel better, delay disease progression and have a positive effect on chronic kidney disease and cardiovascular disease outcomes. 2 This is best achieved by involving patients in the development Recommendations of a personalized management plan. Inrecognitionofthesechallenges, numerousresourceshave GPs can consider asking patient-orientated questions to beendevelopedtosupportandhelpeducateGPsandpatients engage the patient in their management plan. For example, in Australia on the importance of Kidney health, the links Can we set goals for managing this together? and Do between Diabetes, cardiovascular disease, and chronic kidney disease (providing key context youthinkthereareanychallengesyoumightfaceinsticking for treatment advances), and best practices for monitoring, with your management plan? . Empowering patients and diagnosing and treating chronic kidney disease (Figure 1). Here, we provide encouraging them to be part of the decision-making key recommendations to assist GPs in communicating with process, especially around lifestyle, will more likely result patients effectively and to support early detection of chronic kidney disease in lasting positive behavioral changes. GPs can also guide andsuccessful disease management. patients to patient-tailored resources that inform them about Thekidney-consciousGPiseducatedinkidneyhealthand the rationale for their care. Patient-oriented questions may understands theirroleinassessing chronic kidney disease risk.",
    "Patient-oriented questions may understands theirroleinassessing chronic kidney disease risk. Itisimportant need to be adapted once the GP has a better understanding to conduct a full Kidney Health Check for all patients who of the patients personal barriers, beliefs, and preferences. areatincreasedriskofCKDevery12years. 2Thisincludes It should also be acknowledged that the predominant health a Blood test to assess estimated glomerular estimated glomerular filtration rate concerns and priorities, and perceived determinants of (estimated glomerular filtration rate), a Urine albumin-Creatinine ratio (urine albumin-to-creatinine ratio) to check health, may vary between communities, and that GPs for albuminuria, and a Blood Hypertension check (Figure 1). 2 attempts to engage patients may benefit from an awareness Unfortunately, the urine albumin-to-creatinine ratio is often missed in Australian of such differences. general practice, which can lead to missed diagnoses and Withthemanycompetingprioritiesinprimarycare, itis underestimation of chronic kidney disease risk. urine albumin-to-creatinine ratio is a key component of not uncommon for chronic kidney disease to be de-prioritized by time-poor targeted detection of Kidney disease as it is essential for GPs who have a myriad of concerns to address in a short early diagnosis and staging of chronic kidney disease, managing the overall timeframe. Lackoftimehaslongbeenakeyfactorlimiting risk of disease progression, and appropriate use of certain the effective implementation of guidelines by GPs, 11 and medications. has been identified as the biggest barrier to the detection Robson etal 3 Figure1. TipsforimprovingthedetectionandmanagementofCKDinprimarycare. angiotensin-converting enzyme inhibitor, angiotensin-convertingenzymeinhibitor; acute kidney injury, acutekidneyinjury; blood pressure, bloodpressure; chronic kidney disease, chronickidney disease; cardiovascular disease, cardiovasculardisease; estimated glomerular filtration rate, estimatedglomerular filtration rate; GP, general practitioner; HCP, healthcareprofessional; nsMRA, nonsteroidal mineralocorticoid receptor antagonist; Sodium-glucose cotransporter-2 inhibitor, Sodium-glucosecotransporter-2inhibitor; urine albumin-to-creatinine ratio, urinealbumin-Creatinine ratio. and management of chronic kidney disease in primary care. 12 Utilizing the primary healthcare nurses and Diabetes educators may expertise of the whole practice team may be of benefit, as provide support in the identification of High-risk individuwell as implementing practice systems to foster proactive als, detectionofCKD, andcommunicationarounddiagnodetection and management of chronic kidney disease. For example, sis and treatment. Consistent with this, the presence of a 4 Journal of Patient Experience collaborative relationship between members of the health2. KidneyHealthAustralia. Chronickidneydisease(chronic kidney disease)mancare team has been identified as one of the most effective agement in primary care. 5th ed. Kidney Health Australia; enablers of chronic kidney disease detection and management, 12 as well as 2024. Accessed May 14, 2024. helpingtoreduceclinicalinertia. 13Thepresenceofsupporresources/Chronic-Kidney-disease-management-in-primary-caretivetechnologyisalsoakeyenabler, 12andrecentadvance5th-edition-handbook. pdf. ments in artificial intelligence may further enhance 3. Shlipak M, Tummalapalli S, Boulware L, et al. The case for opportunities to utilize technology to achieve efficiencies early identification and intervention of chronic Kidney in primary care. Examples include reducing the burden of disease: conclusions from a Kidney disease: improving global routine administration and clinical tasks, improving diagoutcomes (Kidney Disease: Improving Global Outcomes) controversies conference. Kidney Int. nosis, and increasing patient engagement and compli2021; 99(1): 3447. doi: 10. 1016/j. kint. 2020. 10. 012 ance. 1416 4. Deloitte Access Economics. Changing the chronic Kidney disease landscape: the economic benefits of early detection and treatment. Melbourne, Vic: Report commissioned by Conclusion Kidney Health Australia; 2023. Accessed December 8, 2023. In summary, early diagnosis and management of chronic kidney disease in Economics/deloitte-au-economics-Kidney-health-australiaprimary care are critical in reducing disease progression. report-80323. pdf. By implementing the key recommendations described here 5. Lopez-VargasP, TongA, PhoonR, ChadbanS, ShenY, Craig within their practice, we believe GPs have the opportunity J. Knowledgedeficit of patients with stage 1-4 chronic kidney disease: a focus to drive improved outcomes and quality of life for people group study. Nephrology. 2014; 19(4): 23443. doi: 10. 1111/ living with chronic kidney disease in Australia. nep. 12206 6.",
    "Nephrology. 2014; 19(4): 23443. doi: 10. 1111/ living with chronic kidney disease in Australia. nep. 12206 6. Lopez-Vargas P, Tong A, Howell M, et al. Patient awareness Acknowledgments andbeliefsabouttheriskfactorsandcomorbiditiesassociated Medical writing support was provided by Cara Kingston PhD of with chronic Kidney disease: a mixed-methods study. Oxford PharmaGenesis, Melbourne, Australia and funded by Nephrology (Carlton). 2017; 22(5): 37481. doi: 10. 1111/nep. AstraZeneca, Sydney, Australia in accordance with Good 12829 Publication Practice 2022 (GPP 2022) guidelines ( 7. AustralianBureauofStatistics. AustralianHealthsurvey: bioismpp. org/gpp-2022). medical results for chronic diseases. Australian Bureau of Statistics; 2013. Accessed December 8, 2023. Declaration of Conflicting Interests abs. gov. au/statistics/health/health-conditions-and-risks/australianBR has participated in advisory boards for AstraZeneca and health-survey-biomedical-results-chronic-diseases/2011GSK. GD has no financial conflicts of interests related to the 12chronic-Kidney-disease. contentofthisarticlebuthasprovidededucationalandadvisory 8. Tunnicliffe DJ, Bateman S, Arnold-Chamney M, et al. board consultancy to AstraZeneca. RKSPhas received consulRecommendations for culturally safe clinical Kidney care for tancy fees and honoraria from AstraZeneca, Novo Nordisk first nations Australians: a guideline summary. Med J Aust. and Sanofi-Genzyme and travel support from Novartis. 2023; 219(8): 37485. doi: 10. 5694/mja2. 52114 AstraZeneca reviewed the final draft of the manuscript for 9. Chu C, Chen M, McCulloch C, et al. Patient awareness of medical accuracy prior to submission; any resulting comments chronic kidney disease: asystematicreviewandmeta-analysisofpatient-oriented weretranslatedtotheauthorsfortheirconsiderationandincorporated at the authors discretion. Oxford PharmaGenesis, questions and study setting. Kidney Med. 2021; 3(4): 576 Melbourne, Australia has received funding from AstraZeneca 585. e1. doi: 10. 1016/j. xkme. 2021. 03. 014 tosupportthewritingofthisarticle. 10. NPSMedicineWise. Chronickidneydisease: afocusonearly detection and management. Quality use of medicines briefing Funding paper. NPS MedicineWise; 2022. Accessed December 8, Theauthorsdisclosedreceiptofthefollowingfinancialsupportfor 2023. Chronic_Kidney_Disease_Quality_Use_Meds_BP. pdf. theresearch, authorship, and/orpublicationofthisarticle: Thiswork wassupportedbyAstraZeneca, Sydney, Australia, 11. YarnallKSH, PollakKI, Ã˜stbyeT, KrauseKM, MichenerJL. Primarycare: Isthereenoughtimeforprevention? AmJPublic Health. 2003; 93: 63541. doi: 10. 2105/AJPH. 93. 4. 635 ORCID iD 12. Neale EP, Middleton J, Lambert potassium. Barriers and enablers to BreonnyRobson detection and management of chronic Kidney disease in primary healthcare: A systematic review. BMC Nephrol. References 2020; 21(1): 83. doi: 10. 1186/s12882-020-01731-x 1. Australian Institute of Health and Welfare. Chronic Kidney 13. PowellRE, ZaccardiF, BeebeC, etal. Strategiesforovercomdisease: Australianfacts. 2023; AccessedMay14, 2024. https: // ing therapeutic inertia in type 2 Diabetes: a systematic review www. aihw. gov. au/reports/chronic-Kidney-disease/chronic-Kidneyand meta-analysis. Diabetes Obes Metab. 2021; 23(9): 2137 disease/contents/about. 54. doi: 10. 1111/dom. 14455 Robson etal 5 14. AlKuwaitiA, NazerK, Al-ReedyA, etal. Areviewoftherole position-statements/view-all-position-statements/clinical-andof artificial intelligence in healthcare. J Pers Med. practice-management/artificial-intelligence-in-primary-careref2023; 13(6): 951. doi: 10. 3390/jpm13060951 num-1 15. Royal Australian College of General Practitioners. Artificial 16. SummertonN, CansdaleM. Artificialintelligenceanddiagnointelligence in primary care Position statement. 2021. sisingeneralpractice. Br JGen Pract. 2019; 69(684): 32425. Accessed March 1, 2024. doi: 10. 3399/bjgp19X704165"
  ],
  "metadatas": [
    {
      "source": "10.1177_23743735241256464.pdf",
      "chunk_id": 0,
      "content_type": "recommendation",
      "content_type_confidence": 2,
      "word_count": 561,
      "entity_count": 8,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,albuminuria,creatinine,cardiovascular disease,quality of life,screening,albumin-creatinine ratio",
      "year": "2024",
      "organization": "Unknown"
    },
    {
      "source": "10.1177_23743735241256464.pdf",
      "chunk_id": 1,
      "content_type": "treatment",
      "content_type_confidence": 3,
      "word_count": 573,
      "entity_count": 6,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,glomerular filtration rate,kidney function,albuminuria,cardiovascular disease,monitoring",
      "year": "2024",
      "organization": "Unknown"
    },
    {
      "source": "10.1177_23743735241256464.pdf",
      "chunk_id": 2,
      "content_type": "reference",
      "content_type_confidence": 4,
      "word_count": 595,
      "entity_count": 10,
      "has_ckd": true,
      "has_gfr": true,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,acute kidney injury,glomerular filtration rate,albuminuria,creatinine,sodium,cardiovascular disease,quality of life,stage 1,albumin-creatinine ratio",
      "year": "2024",
      "organization": "Unknown"
    },
    {
      "source": "10.1177_23743735241256464.pdf",
      "chunk_id": 3,
      "content_type": "evidence",
      "content_type_confidence": 5,
      "word_count": 433,
      "entity_count": 3,
      "has_ckd": true,
      "has_gfr": false,
      "has_diabetes": false,
      "has_hypertension": false,
      "has_dialysis": false,
      "medical_entities": "chronic kidney disease,potassium,guideline",
      "year": "2024",
      "organization": "Unknown"
    }
  ],
  "ids": [
    "10.1177_23743735241256464_0",
    "10.1177_23743735241256464_1",
    "10.1177_23743735241256464_2",
    "10.1177_23743735241256464_3"
  ]
}